Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel synthetic biotic to promote mucosal healing for treatment of IBD

June 3, 2021

MCAD as novel therapeutic target for glioblastoma

June 2, 2021

N-803 shows safety and efficacy in combination with rituximab in iNHL

June 2, 2021

ATG3 gene is implicated in the development of NAFLD

June 2, 2021

Irisin and nucleobindin-2 predict cardiovascular risk in patients with NFAI

June 2, 2021

Transine Therapeutics secures funding to advance its novel class of therapeutic RNAs

June 2, 2021

Diverse cohort expands diabetes genomics

June 2, 2021

Copeptin is a prognostic marker in schizophrenia spectrum disorder

June 2, 2021

NIH announces first-in-human study of FluMos-v1 universal influenza vaccine

June 2, 2021

Valo Early Discovery identifies new HDAC8 inhibitors

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...